About

It also can affect people with sickle-cell disease, thalassemia, or alcoholism. People undergoing glucocorticoid therapy can develop the condition. Mixed hypogonadism is more common with increased age. These parts of the brain control hormone production by the testes. Secondary hypogonadism is caused by damage to the pituitary gland or hypothalamus. Fatigue and mental fogginess are some commonly reported mental and emotional symptoms in men with low T. Later in life, insufficient testosterone can lead to other problems.
In a study of elderly men in a nursing home who have experienced hip fractures, 66% were hypogonadal (64). There are many suspected causes of osteoporosis, and the most frequent are corticosteroid use, Cushing’s syndrome, hypogonadism and excessive alcohol consumption. Hip fracture incidence is low until after 75 years, when the risk increases exponentially. Up to 13 million men are at increased risk because of low BMD and up to 2 million of these have osteoporosis (61,62). The mechanism underlying the insulin sensitising effects of testosterone needs to be elucidated. In addition, a small dose (50 mg/day) of testosterone gel improved both glycemic control and insulin sensitivity over and above the improvements because of diet and exercise (60). However, it seems likely that testosterone may suppress insulin resistance independently of its effects on adiposity.
The correlation of voiding symptoms and prostate size is poor, so there may not be any changes in urine flow rates and prostate voiding symptoms. The development of BPH requires androgens, but many studies have failed to show an association with testosterone treatment. Patients with benign prostatic hyperplasia (BPH) treated with androgens are at an increased risk for worsening of signs and symptoms of BPH.
Although serum free testosterone more accurately reflects functional testosterone levels, its measurement requires equilibrium dialysis, which is technically difficult and not widely available. The normal range for total testosterone is 300 to 1000 ng/dL (10.5 to 35 nmol/L). Elevation of serum FSH with normal levels of serum testosterone and LH often occurs when spermatogenesis is impaired but testosterone production is normal. Levels of FSH and LH also help determine whether hypogonadism is primary or secondary. Some syndromes of hypogonadism have both primary and secondary causes (mixed hypogonadism). Any acute systemic illness can cause temporary secondary hypogonadism.
Analysis of gonadotropin levels demonstrates that the hypogonadism in type 2 diabetes is mostly hypogonadotropic (secondary) hypogonadism (40). Large randomised trials using men with and without cardiovascular disease and with cardiovascular end-points are needed to better assess the consequences of testosterone treatment on cardiovascular risk (36). This is in contrast to what was found in the MMAS study where total testosterone levels were unrelated to all-cause mortality (34,35). Human observational studies, however, have shown no associations between high testosterone levels and coronary artery disease, and testosterone has been shown to dilate the coronary arteries both in vitro and in vivo. It is not yet understood whether the low testosterone levels are a consequence of the disease, are connected with the disease’s aetiology, or are one of the causes of the disease. Patients with secondary hypogonadism can have their fertility restored by suitable hormonal stimulation, whereas those with primary hypogonadism resulting from testicular failure cannot.

Gender: Female